Episodebeskrivelse
In the second episode of Hematology CrossTalk, Dr. Gianluca Rotta (Waters™ Biosciences, formerly BD Biosciences) continues the discussion with Prof. Francesco Buccisano (Tor Vergata University of Rome, Italy) and Dr. Vittorio Emanuele Muccio (San Luigi Gonzaga University Hospital, Orbassano, Italy), exploring the evolving role of measurable residual disease (MRD) in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes(MDS).
The conversation looks at how MRD assessment is redefining the definition of complete remission and influencingclinical decision-making. From the laboratory…
Nettsted: podcasters.spotify.com

